We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




X-Ray Crystallography Study Reveals Structure of the Chemokine Receptor CXCR4 in Complex with a Viral Ch

By LabMedica International staff writers
Posted on 01 Feb 2015
Print article
Image: The newly solved structure of the CXCR4 receptor (black) in complex with a chemokine (purple surface). The background shows cell migration, a process driven by chemokines interacting with receptors on cell surfaces (Photo courtesy of Katya Kadyshevskaya, University of Southern California).
Image: The newly solved structure of the CXCR4 receptor (black) in complex with a chemokine (purple surface). The background shows cell migration, a process driven by chemokines interacting with receptors on cell surfaces (Photo courtesy of Katya Kadyshevskaya, University of Southern California).
The crystal structure of the protein complex created by the binding of the cellular receptor CXCR4 (C-X-C chemokine receptor-4) to its ligand has been solved by exploiting the binding characteristics of the viral chemokine analog vMIP-II.

CXCR4 is an alpha-chemokine receptor specific for stromal-derived-factor-1 (SDF-1 also called CXCL12), a molecule with potent chemotactic activity for lymphocytes. This receptor is one of several chemokine receptors that HIV can use to infect CD4+ T-cells. During embryogenesis CXCL12 directs the migration of hematopoietic cells from fetal liver to bone marrow and the formation of large blood vessels. In adulthood, CXCL12 plays an important role in angiogenesis by recruiting endothelial progenitor cells (EPCs) from the bone marrow through a CXCR4 dependent mechanism. It is this function of CXCL12 that makes it a very important factor in carcinogenesis and the formation of new blood vessels that is linked to tumor progression. CXCL12 also has a role in tumor metastasis where cancer cells that express the receptor CXCR4 are attracted to metastasis target tissues that release the ligand, CXCL12.

vMIP-II (also called vCCL2) is a viral chemokine analog that is produced by Human herpesvirus 8. This protein is unique because it binds to a wide range of chemokine receptors even across different subfamilies: it binds to CCR1, CCR2, CCR5, CXCR4 (as an antagonist), and to CCR3 and CCR8 as an agonist.

The structural basis of receptor-chemokine recognition has been a long-standing unanswered question due to the challenges of structure determination for membrane protein complexes. However, investigators at the University of California, San Diego (USA) and their colleagues at the University of Southern California (Los Angeles, USA) have now reported the crystal structure of the chemokine receptor CXCR4 in complex with the viral chemokine antagonist vMIP-II at a resolution of 0.31 nm.

To overcome the difficulties of determining the structure of a membrane protein complex, the investigators combined computational modeling and disulfide trapping to vMIP-II to stabilize the complex. Once stabilized, X-ray crystallography was used to determine the three-dimensional atomic structure for the CXCR4-chemokine complex.

Results published in the January 22, 2015, online edition of the journal Science revealed that each receptor bound a single chemokine molecule, and that the interaction between the receptor and the ligand was more extensive than previously supposed, as there was a single large contiguous binding surface rather than two separate binding sites.

"This new information could ultimately aid the development of better small molecular inhibitors of CXCR4-chemokine interactions—inhibitors that have the potential to block cancer metastasis or viral infections," said senior author Dr. Tracy M. Handel, professor of pharmacology at the University of California, San Diego.

Related Links:

University of California, San Diego
University of Southern California


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Chemistry Analyzer
MS100
New
Newborn Screening Test
NeoMass AAAC 3.0

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.